Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

AN2 Therapeutics, Inc. - Common Stock (NQ: ANTX )

8.750 -0.030 (-0.34%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 24, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 432,920
Open 8.650
Bid (Size) 8.580 (2)
Ask (Size) 11.89 (1)
Prev. Close 8.780
Today's Range 8.410 - 9.860
52wk Range 7.430 - 23.58
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
89 Biggest Movers From Friday
Gainers Revlon, Inc. (NYSE: REV) jumped 91.3% to close at $3.73 on Friday after the company filed for Chapter 11 bankruptcy. 
Via Benzinga
RA Capital-Backed AN2 Therapeutics Hits NASDAQ, With IPO Price At $15
 
Via Benzinga

Performance

YTD
-43.18%
-43.18%
1 Month
-27.02%
-27.02%
3 Month
-43.18%
-43.18%
6 Month
-43.18%
-43.18%
1 Year
-43.18%
-43.18%

More News

Read More
79 Biggest Movers From Yesterday
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
81 Biggest Movers From Yesterday
Via Benzinga
AN2 Therapeutics Appoints Maggie FitzPatrick to Its Board of Directors
From AN2 Therapeutics, Inc.
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For April 19, 2022
Via Benzinga
The Week Ahead In Biotech (April 17-April 23): J&J, Abbott Earnings, Adcom Test For TG Therapeutics And More
Via Benzinga
Opening Day: AN2 Therapeutics Rises In Public Debut After Upsized IPO
Via Talk Markets
The Daily Biotech Pulse: MEI Pharma Wilts On Adverse Regulatory Development, Decision Day For Zogenix, AN2 Therapeutics IPO
Via Benzinga
Preview: An2 Therapeutics, Inc Set To IPO Tomorrow
Via Benzinga
Increased R&D Activities Have Fueled Growth and Promise for Pancreatic Cancer Treatment
Via FinancialNewsMedia
Topics Death
Exposures Death
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.